Patents by Inventor Ruslan Y. Tsivkovski

Ruslan Y. Tsivkovski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
    Publication number: 20220080047
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Application
    Filed: April 26, 2021
    Publication date: March 17, 2022
    Inventors: Michael N. DUDLEY, Ruslan Y. TSIVKOVSKI, David C. GRIFFITH, Olga RODNY
  • Topical use of levofloxacin for reducing lung inflammation
    Patent number: 11020481
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Grant
    Filed: October 11, 2017
    Date of Patent: June 1, 2021
    Assignee: Horizon Orphan LLC
    Inventors: Michael N. Dudley, Ruslan Y. Tsivkovski, David C. Griffith, Olga Rodny
  • TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
    Publication number: 20180085462
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Application
    Filed: October 11, 2017
    Publication date: March 29, 2018
    Inventors: Michael N. Dudley, Ruslan Y. Tsivkovski, David C. Griffith, Olga Rodny
  • TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
    Publication number: 20140105985
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Application
    Filed: December 19, 2013
    Publication date: April 17, 2014
    Applicant: Mpex Pharmaceuticals, Inc.
    Inventors: Michael N. Dudley, Ruslan Y. Tsivkovski, David C. Griffith, Olga Rodny
  • Topical use of Levofloxacin for reducing lung inflammation
    Patent number: 8629139
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Grant
    Filed: October 6, 2009
    Date of Patent: January 14, 2014
    Assignee: MPEX Pharmaceuticals, Inc.
    Inventors: Michael N. Dudley, Ruslan Y. Tsivkovski, David C. Griffith, Olga Rodny
  • TOPICAL USE OF LEVOFLOXACIN FOR REDUCING LUNG INFLAMMATION
    Publication number: 20100087386
    Abstract: The present invention relates to methods and compositions for the treatment of pulmonary inflammation. In particular, methods and compositions using aerosol levofloxacin or ofloxacin to reduce pulmonary inflammation are provided.
    Type: Application
    Filed: October 6, 2009
    Publication date: April 8, 2010
    Applicant: MPEX PHARMACEUTICALS, INC.
    Inventors: Michael N. Dudley, Ruslan Y. Tsivkovski, David C. Griffith, Olga Rodny